Home › Trial NCT01836926
TaTME Versus Open Intersphincteric Resection After Neoadjuvant Concurrent Chemoradiotherapy.
- Trial IDNCT01836926
- StatusCompleted
- PhaseN/A
- Study typeInterventional
- SponsorOsama Mohammad Ali ElDamshety
- Enrollment110
- Start date2013-04
- ConditionsRectal Cancer
Enriched analysis
Parsed endpoints, structured eligibility, drug class and a plain-English summary — shown to verified visitors to prevent automated scraping.
Trial data from ClinicalTrials.gov (U.S. public domain) and ISRCTN (CC BY 4.0), used with attribution. TrialLens is an independent index, not affiliated with or endorsed by ClinicalTrials.gov, the NIH, or any trial sponsor. For research only — not medical advice.